Developmental changes in human dopamine neurotransmission: Cortical receptors and terminators

BMC Neuroscience

Volumn 13, Issue 1, 2012, Pages

  Rothmond, Debora A ^a,b,c   Weickert, Cynthia S ^a,b,c   Webster, Maree J ^d  

^a Schizophrenia Research Unit   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d Stanley Laboratory of Brain Research   (United States)

Author keywords

ADHD; COMT; DLPFC; Dopamine receptor; DRD; MAOA; MAOB; Postmortem; Schizophrenia; Tyrosine hydroxylase

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CATECHOL METHYLTRANSFERASE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE; AMINE OXIDASE (FLAVIN CONTAINING); DOPAMINE RECEPTOR;

ARTICLE; BRAIN DEVELOPMENT; COHORT ANALYSIS; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; MICROARRAY ANALYSIS; POSTNATAL DEVELOPMENT; POSTSYNAPTIC POTENTIAL; PREFRONTAL CORTEX; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; WESTERN BLOTTING; WORKING MEMORY; ADOLESCENT; ADULT; AGE; ANALYSIS OF VARIANCE; CHILD; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; INFANT; MALE; METABOLISM; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; CATECHOL O-METHYLTRANSFERASE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MONOAMINE OXIDASE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE; YOUNG ADULT;

EID: 84857010310     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-13-18     Document Type: Article

References (81)

1. Goldman-Rakic PS. Development of cortical circuitry and cognitive function. Child Dev 1987, 58(3):601-622. 10.2307/1130201, 3608641.
2. Luna B, Thulborn KR, Munoz DP, Merriam EP, Garver KE, Minshew NJ, Keshavan MS, Genovese CR, Eddy WF, Sweeney JA. Maturation of widely distributed brain function subserves cognitive development. NeuroImage 2001, 13(5):786-793. 10.1006/nimg.2000.0743, 11304075.
3. Swanson HL. What develops in working memory? A life span perspective. Developmental Psychology 1999, 35(4):986-1000.
4. Huizinga M, Dolan CV, van der Molen MW. Age-related change in executive function: Developmental trends and a latent variable analysis. Neuropsychologia 2006, 44(11):2017-2036. 10.1016/j.neuropsychologia.2006.01.010, 16527316.
5. Jolles DD, Kleibeuker SW, Rombouts SARB, Crone EA. Developmental differences in prefrontal activation during working memory maintenance and manipulation for different memory loads. Developmental Science 2011, 14(4):713-724. 10.1111/j.1467-7687.2010.01016.x, 21676092.
6. Romanides AJ, Duffy P, Kalivas PW. Glutamatergic and dopaminergic afferents to the prefrontal cortex regulate spatial working memory in rats. Neuroscience 1999, 92(1):97-106. 10.1016/S0306-4522(98)00747-7, 10392833.
7. Williams GV, Goldman-Rakic PS. Modulation of memory fields by dopamine Dl receptors in prefrontal cortex. Nature 1995, 376(6541):572-575. 10.1038/376572a0, 7637804.
8. Lewis DA. Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology 1997, 16:385-398. 10.1016/S0893-133X(96)00277-1, 9165494.
9. Glickstein SB, DeSteno DA, Hof PR, Schmauss C. Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention. Cerebral Cortex 2005, 15(7):1016-1024.
10. Goldman-Rakic PS. Regional and cellular fractionation of working memory. Proceedings of the National Academy of Sciences of the USA 1996, 93(24):13473-13480. 10.1073/pnas.93.24.13473, 33633, 8942959.
11. Mizoguchi K, Shoji H, Tanaka Y, Maruyama W, Tabira T. Age-related spatial working memory impairment is caused by prefrontal cortical dopaminergic dysfunction in rats. Neuroscience 2009, 162(4):1192-1201. 10.1016/j.neuroscience.2009.05.023, 19463906.
12. Winter S, Dieckmann M, Schwabe K. Dopamine in the prefrontal cortex regulates rats behavioral flexibility to changing reward value. Behavioural Brain Research 2009, 198(1):206-213. 10.1016/j.bbr.2008.10.040, 19041903.
13. Berger B, Gaspar P, Verney C. Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends in Neurosciences 1991, 14(1):21-27. 10.1016/0166-2236(91)90179-X, 1709528.
14. Rosenberg DR, Lewis DA. Changes in the dopaminergic innervation of monkey prefrontal cortex during late postnatal development: A tyrosine hydroxylase immunohistochemical study. Biological Psychiatry 1994, 36(4):272-277. 10.1016/0006-3223(94)90610-6, 7986893.
15. Lambe EK, Krimer LS, Goldman-Rakic PS. Differential postnatal development of catecholamine and serotonin inputs to identified neurons in prefrontal cortex of rhesus monkey. J of Neuroscience 2000, 20(23):8780-8787.
16. Noisin EL, Thomas WE. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex. Brain Research 1988, 469(1-2):241-252.
17. Tarazi FI, Baldessarini RJ. Comparative postnatal development of dopamine D1, D2 and D4 receptors in rat forebrain. Int'l J of Developmental Neuroscience 2000, 18(1):29-37. 10.1016/S0736-5748(99)00108-2, 22336831.
18. Araki KY, Sims JR, Bhide PG. Dopamine receptor mRNA and protein expression in the mouse corpus striatum and cerebral cortex during pre- and postnatal development. Brain Research 2007, 1156:31-45. 1994791, 17509542.
19. Wong DF, Broussolle EP, Wand G, Villemagne V, Dannals RF, Links JM, Zacur HA, Harris J, Naidu S, Braestrup C, et al. In vivo measurement of dopamine receptors in human brain by positron emission tomography age and sex differencesa. Annals of the New York Academy of Sciences 1988, 515(1):203-214. 10.1111/j.1749-6632.1988.tb32986.x, 2966605.
20. Jucaite A, Forssberg H, Karlsson P, Halldin C, Farde L. Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study. Neuroscience 2010, 167(1):104-110. 10.1016/j.neuroscience.2010.01.034, 20109534.
21. Kornhuber J, Konradi C, Mack-Burkhardt F, Riederer P, Heinsen H, Beckmann H. Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex. Brain Research 1989, 499(1):81-86. 10.1016/0006-8993(89)91136-0, 2804672.
22. Tunbridge EM, Weickert CS, Kleinman JE, Herman MM, Chen J, Kolachana BS, Harrison PJ, Weinberger DR. Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. Cereb Cortex 2007, 17(5):1206-1212.
23. Bell MA, Wolfe CD. Changes in brain functioning from infancy to early childhood: evidence from EEG power and coherence during working memory tasks. Developmental Neuropsychology 2007, 31(1):21-38. 10.1207/s15326942dn3101_2, 17305436.
24. Lackner CL, Bowman LC, Sabbagh MA. Dopaminergic functioning and preschoolers' theory of mind. Neuropsychologia 2010, 48(6):1767-1774. 10.1016/j.neuropsychologia.2010.02.027, 20206642.
25. Sabbagh MA, Bowman LC, Evraire LE, Ito JMB. Neurodevelopmental correlates of theory of mind in preschool children. Child Development 2009, 80(4):1147-1162. 10.1111/j.1467-8624.2009.01322.x, 19630899.
26. Carlson SM. Developmentally sensitive measures of executive function in preschool children. Developmental Neuropsychology 2005, 28(2):595-616. 10.1207/s15326942dn2802_3, 16144429.
27. Davidson MC, Amso D, Anderson LC, Diamond A. Development of cognitive control and executive functions from 4 to 13 years: Evidence from manipulations of memory, inhibition, and task switching. Neuropsychologia 2006, 44(11):2037-2078. 10.1016/j.neuropsychologia.2006.02.006, 1513793, 16580701.
28. Biederman J. Attention-Deficit/Hyperactivity Disorder: a selective overview. Biological Psychiatry 2005, 57(11):1215-1220. 10.1016/j.biopsych.2004.10.020, 15949990.
29. Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ, Williams GV. Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology 2004, 174(1):3-16.
30. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1987, 1:133-152. 10.1002/syn.890010203, 2905529.
31. Gray JA, Roth BL. Molecular targets for treating cognitive dysfunction in schizophrenia. Schizophrenia Bulletin 2007, 33(5):1100-1119. 10.1093/schbul/sbm074, 2632344, 17617664.
32. Kellendonk C, Simpson EH, Polan HJ, Malleret G, Vronskaya S, Winiger V, Moore H, Kandel ER. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 2006, 49(4):603-615. 10.1016/j.neuron.2006.01.023, 16476668.
33. Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O, Someya Y, Sassa T, Sudo Y, Matsushima E, et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 1997, 385(6617):634-636. 10.1038/385634a0, 9024661.
34. Weickert TW, Goldberg TE, Gold JM, Bigelow LB, Egan MF, Weinberger DR. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry 2000, 57(9):907-913. 10.1001/archpsyc.57.9.907, 10986554.
35. Lidow MS, Rakic P. Scheduling of monoaminergic neurotransmitter receptor expression in the primate neocortex during postnatal development. Cerebral Cortex 1992, 2(5):401-416. 10.1093/cercor/2.5.401, 1330122.
36. Weickert CS, Webster MJ, Gondipalli P, Rothmond D, Fatula RJ, Herman MM, Kleinman JE, Akil M. Postnatal alterations in dopaminergic markers in the human prefrontal cortex. Neuroscience 2007, 144(3):1109-1119. 10.1016/j.neuroscience.2006.10.009, 17123740.
37. Goldman-Rakic PS, Muly IEC, Williams GV. D1 receptors in prefrontal cells and circuits. Brain Research Reviews 2000, 31(2-3):295-301. 10.1016/S0165-0173(99)00045-4, 10719156.
38. Finn AS, Sheridan MA, Kam CLH, Hinshaw S, D'Esposito M. Longitudinal evidence for functional specialization of the neural circuit supporting working memory in the human brain. The Journal of Neuroscience 2010, 30(33):11062-11067. 10.1523/JNEUROSCI.6266-09.2010, 2952435, 20720113.
39. Rubia K, Smith AB, Woolley J, Nosarti C, Heyman I, Taylor E, Brammer M. Progressive increase of frontostriatal brain activation from childhood to adulthood during event-related tasks of cognitive control. Human Brain Mapping 2006, 27(12):973-993. 10.1002/hbm.20237, 16683265.
40. Sunahara RK, Guan H-C, O'Dowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Van Tol HHM, Niznik HB. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 1991, 350(6319):614-619. 10.1038/350614a0, 1826762.
41. Bombin I, Arango C, Mayoral M, Castro-Fornieles J, Gonzalez-Pinto A, Gonzalez-Gomez C, Moreno D, Parellada M, Baeza I, Graell M, et al. DRD3, but not COMT or DRD2, genotype affects executive functions in healthy and first-episode psychosis adolescents. Am J of Medical Genetics Part B: Neuropsychiatric Genetics 2008, 147B(6):873-879.
42. Herrmann MJ, Walter A, Schreppel T, Ehlis AC, Pauli P, Lesch KP, Fallgatter AJ. D4 receptor gene variation modulates activation of prefrontal cortex during working memory. European J of Neuroscience 2007, 26(10):2713-2718.
43. Bordelon-Glausier JR, Khan ZU, Muly EC. Quantification of D1 and D5 dopamine receptor localization in layers I, III, and V of Macaca mulatta prefrontal cortical area 9: coexpression in dendritic spines and axon terminals. J of Comparative Neurology 2008, 508(6):893-905.
44. Amico F, Spowart-Manning L, Anwyl R, Rowan MJ. Performance- and task-dependent effects of the dopamine D1/D5 receptor agonist SKF 38393 on learning and memory in the rat. Euro J of Pharmacology 2007, 577(1-3):71-77.
45. Rani M, Kanungo MS. Expression of D2 dopamine receptor in the mouse brain. Biochemical and Biophysical Research Communications 2006, 344(3):981-986. 10.1016/j.bbrc.2006.03.075, 16643854.
46. Mack KJ, O'Malley KL, Todd RD. Differential expression of dopaminergic D2 receptor messenger RNAs during development. Developmental Brain Research 1991, 59(2):249-251. 10.1016/0165-3806(91)90105-R, 1833091.
47. Nair VD, Mishra RK. Ontogenic development of dopamine D4 receptor in rat brain. Developmental Brain Research 1995, 90(1-2):180-183. 10.1016/0165-3806(96)83499-7, 8719342.
48. Bandyopadhyay S, Hablitz JJ. Dopaminergic modulation of local network activity in rat prefrontal cortex. Journal of Neurophysiology 2007, 97(6):4120-4128. 10.1152/jn.00898.2006, 17392423.
49. Gulledge AT, Jaffe DB. Dopamine decreases the excitability of layer V pyramidal cells in the rat prefrontal cortex. The Journal of Neuroscience 1998, 18(21):9139-9151.
50. Zhou F-M, Hablitz JJ. Dopamine modulation of membrane and synaptic properties of interneurons in rat cerebral cortex. J of Neurophysiology 1999, 81(3):967-976.
51. Krimer LS, Jakab RL, Goldman-Rakic PS. Quantitative three-dimensional analysis of the catecholaminergic innervation of identified neurons in the macaque prefrontal cortex. J of Neuroscience 1997, 17(19):7450-7461.
52. Erickson SL, Lewis DA. Postnatal development of parvalbumin- and GABA transporter-immunoreactive axon terminals in monkey prefrontal cortex. J of Comparative Neurology 2002, 448(2):186-202.
53. Fung SJ, Webster MJ, Sivagnanasundaram S, Duncan C, Elashoff M, Weickert CS. Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. Am J Psychiatry 2010, 167(12):1479-1488. 10.1176/appi.ajp.2010.09060784, 21041246.
54. Webster MJ, Elashoff M, Weickert CS. Molecular evidence that cortical synaptic growth predominates during the first decade of life in humans. Int'l J of Developmental Neuroscience 2011, 29(3):225-236. 10.1016/j.ijdevneu.2010.09.006, 22336831.
55. Tarazi FI, Tomasini EC, Baldessarini RJ. Postnatal development of dopamine D4-like receptors in rat forebrain regions: comparison with D2-like receptors. Developmental Brain Research 1998, 110(2):227-233. 10.1016/S0165-3806(98)00111-4, 9748595.
56. Meador-Woodruff JH, Damask SP, Wang J, Haroutunian V, Davis KL, Watson SJ. Dopamine receptor mRNA expression in human striatum and neocortex. Neurospsychopharmacology 1996, 15:17-29.
57. Matsumoto M, Hidaka K, Tada S, Tasaki Y, Yamaguchi T. Low levels of mRNA for dopamine D4 receptor in human cerebral cortex and striatum. J of Neurochemistry 1996, 66(3):915-919.
58. Zecevic N, Verney C. Development of the catecholamine neurons in human embryos and foetuses, with special emphasis on the innervation of the cerebral cortex. J of Comparative Neurology 1995, 351(4):509-535.
59. Zhou Q-Y, Quaife CJ, Palmiter RD. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 1995, 374(6523):640-643. 10.1038/374640a0, 7715703.
60. Jourdikian F, Tabakoff B, Alivisatos SGA. Ontogeny of multiple forms of monoamine oxidase in mouse brain. Brain Research 1975, 93(2):301-308. 10.1016/0006-8993(75)90352-2, 809102.
61. Kalaria RN, Harik SI. Blood-brain barrier monoamine oxidase: enzyme characterization in cerebral microvessels and other tissues from six mammalian species, including human. J of Neurochemistry 1987, 49(3):856-864.
62. Rao MK, Nagendra SN, Subhash MN. Monoamine oxidase isoenzymes in rat brain: differential changes during postnatal development but not aging. Neurobiology of Aging 1995, 16(5):833-836. 10.1016/0197-4580(95)00061-I, 8532118.
63. Vitalis T, Alvarez C, Chen K, Shih JC, Gaspar P, Cases O. Developmental expression pattern of monoamine oxidases in sensory organs and neural crest derivatives. J of Comparative Neurology 2003, 464(3):392-403.
64. Lakshmana MK, Rao BSS, Dhingra NK, Ravikumar R, Govindaiah, Sudha S, Meti BL, Raju TR. Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain. Neurochemical Research 1998, 23(8):1031-1037. 10.1023/A:1020799700885, 9704592.
65. Matsumoto M, Weickert CS, Akil M, Lipska BK, Hyde TM, Herman MM, Kleinman JE, Weinberger DR. Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience 2003, 116(1):127-137. 10.1016/S0306-4522(02)00556-0, 12535946.
66. Mundorf ML, Joseph JD, Austin CM, Caron MG, Wightman RM. Catecholamine release and uptake in the mouse prefrontal cortex. J of Neurochemistry 2001, 79(1):130-142.
67. Carboni E, Silvagni A. Dopamine reuptake by norepinephrine neurons: exception or rule?. Crit Rev Neurobiol 2004, 16(1-2):121-128. 10.1615/CritRevNeurobiol.v16.i12.130, 15581407.
68. Westlund KN, Denney RM, Kochersperger LM, Rose RM, Abell CW. Distinct monoamine oxidase A and B populations in primate brain. Science 1985, 230(4722):181-183. 10.1126/science.3875898, 3875898.
69. Karoum F, Chrapusta SJ, Egan MF. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J of Neurochemistry 1994, 63(3):972-979.
70. Shirakawa T, Abe M, Oshima S, Mitome M, Oquchi H. Neuronal expression of catechol O-methyltransferase mRNA in neonatal rat suprachiasmatic nucleus. Neuroreport 2004, 15(8):1239-1243. 10.1097/01.wnr.0000127635.38052.cd, 15167541.
71. Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ, O'Donovan MC. A haplotype implicated in schizophrenia susceptibilityis associated with reduced COMT expression in human brain. The American Journal of Human Genetics 2003, 73(1):152-161.
72. Matsumoto M, Weickert CS, Beltaifa S, Kolachana B, Chen J, Hyde TM, Herman MM, Weinberger DR, Kleinman JE. Catechol O-Methyltransferase (COMT) mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia. Neuropsychopharmacology 2003, 28(8):1521-1530. 10.1038/sj.npp.1300218, 12799619.
73. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, et al. Functional analysis of genetic variation in Catechol-O-Methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J of Human Genetics 2004, 75(5):807-821.
74. del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW. The roles of dopamine and noradrenaline in the pathophysiology and treatment of Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry 2011, 69(12):e145-e157. 10.1016/j.biopsych.2011.02.036, 21550021.
75. Mattai A, Hill J, Lenroot R. Treatment of early-onset schizophrenia. Current Opinion in Psychiatry 2010, 23(4):304-310. 10.1097/YCO.0b013e32833b027e, 20502331.
76. Zielke H, Wisniewski S, Stein S. Brief report: the role of national brain and tissue banks in research on autism and developmental disorders. J of Autism and Developmental Disorders 1996, 26(2):227-230.
77. Kozlovsky N, Shanon-Weickert C, Tomaskovic-Crook E, Kleinman JE, Belmaker RH, Agam G. Reduced GSK-3ß mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients. J of Neural Transmission 2004, 111(12):1583-1592.
78. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta]CT method. Methods 2001, 25(4):402-408. 10.1006/meth.2001.1262, 11846609.
79. Mimmack ML, Ryan M, Baba H, Navarro-Ruiz J, Iritani S, Faull RLM, McKenna PJ, Jones PB, Arai H, Starkey M, et al. Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proceedings of the National Academy of Sciences of the USA 2002, 99(7):4680-4685. 10.1073/pnas.032069099, 123707, 11930015.
80. Weickert CS, Elashoff M, Richards AB, Sinclair D, Bahn S, Paabo S, Khaitovich P, Webster MJ. Transcriptome analysis of male-female differences in prefrontal cortical development. Mol Psychiatry 2009, 14(6):558-561. 10.1038/mp.2009.5, 19455171.
81. Sinclair D, Webster MJ, Wong J, Weickert CS. Dynamic molecular and anatomical changes in the glucocorticoid receptor in human cortical development. Mol Psychiatry 2011, 16(5):504-515. 10.1038/mp.2010.28, 20308989.